Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options
September 27, 2024 09:19 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes Drugs...
Global Emerging Insulin Drug and Delivery Technologies Market Analysis: Smart Pens Unveiled as Fastest-Growing Segment, Predicted to Register CAGR of 12.6% During 2023-2028
March 08, 2024 04:15 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials" report has been added to ResearchAndMarkets.com's...
Europe Insulin Pens Market Projected to Reach USD 2.29 Billion by 2028 - Technological Innovations and Rising Diabetes Prevalence Fueling Growth
January 30, 2024 19:58 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...